Implenia takes over BAM Swiss AG
Implenia buys BAM Swiss AG from Basel. The two companies are already working together on the realization of the Aarau Cantonal Hospital. With the takeover, Implenia will also implement further BAM Swiss projects in Basel and Zurich.
Implenia and BAM Swiss signed an agreement on March 29 for the takeover of BAM Swiss AG by the Dietlikon construction and real estate company, Implenia informed in a press release . The acquisition is intended to strengthen Implenia's competitive position in future tenders. In addition, this will make the company “a leading construction service provider in the healthcare sector,” writes Implenia.
Both companies are involved in the realization of the Aarau Cantonal Hospital. Implenia, BAM Swiss AG and BAM Deutschland AG have so far been involved, explains Implenia in the press release. In the future, the project is to be implemented “from a single source”.
The new acquisition also gives Implenia a stronger presence in north-western Switzerland. Specifically, Implenia's project portfolio will be strengthened with the construction of a laboratory and research building for biosystems science and engineering in Basel and the Felix-Platter Spital project in Basel. In Zurich, Implenia will also take on the construction of a student residence hall for the Swiss Federal Institute of Technology Zurich through the acquisition.
"With this transaction, Implenia is strengthening its market presence and is becoming a leading construction service provider in the healthcare sector in Switzerland, an industry with great growth potential in terms of real estate," Implenia CEO André Wyss is quoted in the press release. "The acquisition is in line with our strategy and the goal of Implenia's Buildings Division to expand its market share as a total contractor for complex, large-scale projects."